نتائج البحث

Comparison of Bleeding Risk Between Rivaroxaban and Apixaban for the Treatment of Acute Venous Thromboembolism (COBRRA)

• Authors : Canadian Venous Thromboembolism Clinical Trials and Outcomes Research (CanVECTOR) Network; Canadian Institutes of Health Research (CIHR)

• Source: Comparison of Bleeding Risk Between Rivaroxaban and Apixaban for the Treatment of Acute Venous Thromboembolism

تفاصيل العنوان

Iatrogenic hemorrhage and extensive venous thromboembolism during iTTP treatment with caplacizumab-A case report

• Authors : Boberg, E; Kimiaei, A; Karlström, C

Subjects: Medicin och hälsovetenskap

• Source: EJHaem. 5(4):768-771

تفاصيل العنوان

Comparison of rivaroxaban and low molecular weight heparin in the treatment of cancer-associated venous thromboembolism: a Swedish national population-based register study

• Authors : Linder, M; Ekbom, A; Brobert, G

Subjects: Medicin och hälsovetenskap

• Source: Journal of thrombosis and thrombolysis. 57(6):973-983

تفاصيل العنوان

Proteomic insights into modifiable risk of venous thromboembolism and cardiovascular comorbidities

• Authors : Yuan, S; Xu, FZ; Zhang, H

Subjects: Medicin och hälsovetenskap

• Source: Journal of thrombosis and haemostasis : JTH. 22(3):738-748

تفاصيل العنوان

TRanEXamic Acid to Decrease Heavy Menstrual Bleeding in Individuals Anticoagulated for Venous Thromboembolism Pilot Study (T-REX HMB)

• Authors : Canadian Venous Thromboembolism Clinical Trials and Outcomes Research (CanVECTOR) Network; Jameel Abdulrehman, Staff Hematologist

• Source: TRanEXamic Acid to Decrease Heavy Menstrual Bleeding in Individuals Anticoagulated for Venous Thromboembolism Pilot Study

تفاصيل العنوان

Venous Thromboembolism Risk in Hematological Malignancies Post-Chimeric Antigen Receptor T-Cell (CAR-T) Therapy: A Meta-Analysis of Phase 2 and Phase 3 Clinical Trials.

• Authors : Chitkara, Akshit; Sreenivasan, Sushanth; Yin, Yue

Subjects: B-cell lymphoma; Chimeric Antigen Receptor T-cell (CAR-T); hematological malignancies

• Source: Current Oncology. 31(8)

تفاصيل العنوان

Association between venous thromboembolism and atrial fibrillation: a Mendelian randomization study.

• Authors : Dang C; Department of Infectious Diseases, Tongji Hospital, School of Medicine, Tongji University, Shanghai, 200065, China.; Liao W

Subjects: Atrial Fibrillation*/Atrial Fibrillation*/Atrial Fibrillation*/genetics ; Atrial Fibrillation*/Atrial Fibrillation*/Atrial Fibrillation*/complications ; Mendelian Randomization Analysis*

• Source: BMC medical genomics [BMC Med Genomics] 2024 Oct 29; Vol. 17 (1), pp. 258. Date of Electronic Publication: 2024 Oct 29.Publisher: BioMed Central Country of Publication: England NLM ID: 101319628 Publication Model: Electronic Cited Medium: Internet ISSN: 1755-8794

تفاصيل العنوان

Simple, Effective and Validated. VTE CASE Risk Assessment Score for Venous Thromboembolism in Metastatic Germ Cell Tumour Patients Before First-Line Chemotherapy.

• Authors : Michalski W; Department of Urological Cancer, Maria Skłodowska-Curie National Research Institute of Oncology, Warsaw, Poland.; Macios A

Subjects: Venous Thromboembolism*/Venous Thromboembolism*/Venous Thromboembolism*/etiology ; Venous Thromboembolism*/Venous Thromboembolism*/Venous Thromboembolism*/drug therapy ; Neoplasms, Germ Cell and Embryonal*/Neoplasms, Germ Cell and Embryonal*/Neoplasms, Germ Cell and Embryonal*/drug therapy

• Source: Cancer medicine [Cancer Med] 2024 Oct; Vol. 13 (19), pp. e70295.Publisher: John Wiley & Sons Ltd Country of Publication: United States NLM ID: 101595310 Publication Model: Print Cited Medium: Internet ISSN:

تفاصيل العنوان

Computerized Registry of Patients With Venous Thromboembolism (RIETE) (RIETE)

• Authors : Manuel Monreal, Professor of Internal Medicine

• Source: Computerized Registry of Patients With Venous Thromboembolism (RIETE)Prandoni P, Pesavento R, Bilora F, Fernandez Reyes JL,

تفاصيل العنوان

An Observational Study to Learn More About How Safe Treatment With Rivaroxaban is in Children in Japan With Venous Thromboembolism

• Authors : Janssen Pharmaceutical Companies (formerly Johnson & Johnson Pharmaceutical Research & Development L.L.C.)

• Source: Post-Marketing Database Study for Rivaroxaban in Patients With Pediatric VTE

تفاصيل العنوان